Latest advances and outcomes from the treatment of acute leukemia today
Leukemia is a blood cancer that can be identified by the rapid growth of defective
blood cells. The marrow of our bone produces most of the blood in our body which is
the site of this abnormal growth. Typically, leukemia cells are immature white blood
cells. Leukemic cells alter the normal blood cell formation process, leading to various
signs and symptoms such as bleeding, infection, and tiredness.
There are two kinds of leukemia: acute leukemia and chronic leukemia. Further, the
acute type was classified into acute myeloid leukaemia (AML) and acute
lymphoblastic leukaemia (ALL). Myeloblasts, or defective white blood cells, are the
cause of acute myeloid leukaemia (AML). Acute myelogenous, granulocytic,
nonlymphocytic, or myeloblastic leukaemia are other terms for this kind of cancer.
However, the overproduction of lymphocytes is caused by acute lymphoblastic
leukaemia (ALL).
Stem cell transplantation, radiation therapy, and chemotherapy have been the
cornerstones of leukaemia treatment. Targeted therapy has also been included in the
standard of care for certain kinds of leukaemia within the past 20 years. These
medications target the proteins that regulate the growth, division, and metastasis of
cancer cells. Different treatment combinations are needed for different forms of
leukaemia.
For Acute lymphocytic leukemia (ALL), Immunotherapies are being used where
many elderly people are unable to handle the severe side effects of the intense
chemotherapy therapies required to treat ALL. Compared to chemotherapy, targeted
therapies might have fewer adverse effects.
Immunotherapies are treatments that enhance the body's ability to fight cancer
through the immune system. Currently, four immunotherapies are FDA approved for
the treatment of ALL: blinatumomab, inotuzumab ozogamicin, tisagenlecleucel and
midostaurin. In ALL, the following immunotherapy techniques are being tested or
employed are CAR T-cell therapy and bispecific T-cell engagers (BiTEs). A sort of
cancer treatment called CAR T-cell therapy involves genetically modifying the
patient & own immune cells. For the treatment of some children and young adults with
ALL, one kind of CAR T cell therapy is currently approved. Dosing is based on
weight reported at the time of leukapheresis.The use of this type in elderly B-cell
ALL patients is now being investigated. Adults with B-cell precursor ALL who have
not responded to previous treatment or have returned after treatment have been
approved for another course of CAR T-cell therapy.
Bispecific T-cell engagers (BiTEs) are another immunotherapy that is being studied
for ALL. These medications bind to both cancer and immune cells, drawing the two
groups of cells closer together so that the immune cells can locate and eliminate the
cancer cells with ease. Recently, it was demonstrated that one such BiTE,
blinatumomab, can increase survival for ALL patients in remission following
chemotherapy, even in situations where the disease is completely eradicated.
Acute myeloid leukaemia (AML) tends to be aggressive and was harder to treat than
ALL. However, AML cells sometimes have gene changes that cause the tumors to
grow but can be targeted with new drugs. The management of AML involves two
phases such as remission induction therapy (first phase of treatment to kill
the leukemia cells in the blood and bone marrow ) and remission continuation therapy
(second phase of treatment to kill any remaining leukemia cells).
The treatment of AML includes chemotherapy (drugs to stop the growth of cancer
cells), radiation therapy (uses high-energy x-rays or other types of radiation to kill
cancer cells), stem cell transplant (to replace the blood-forming cells from the blood
or bone marrow of the patient) and targeted therapy (drugs or other substances to
identify and attack specific cancer cells) or combination of both. Targeted treatments
such as Enasidenib, Olutasidenib, Ivosidenib, Venetoclax, Gemtuzumab ozogamicin,
Midostaurin, Gilteritinib, Glasdegib, and Quizartinib have recently been approved to
treat AML with specific gene alterations.
In order to achieve complete remission (CR) from acute leukaemia, standard
treatment paradigms have involved high-intensity induction chemotherapy. In certain
cases, this was followed by an allogeneic hematopoietic cell transplant (allo-HCT) to
eliminate residual disease through the "graft versus leukaemia effect, which is
mediated by the immune cells of the donor. Allo-HCT is not recommended for all
patients, though, and one of the biggest problems facing the industry at the moment is
the lack of viable chemotherapy-based choices for patients who relapse after allo-
HCT or who develop chemotherapy-refractory illness.
The potential of immunotherapy in the treatment of acute myeloid leukaemia (AML)
has been established by the effectiveness of allogeneic stem cell transplantation.
Alternative T-cell-based immunotherapies have demonstrated effectiveness, but there
is a chance that they could cause on-target off-leukemia hematotoxicity. Currently,
the use of adoptive autologous or allogeneic chimeric antigen receptor (CAR) T /
natural killer cell treatment as a bridge-to-transplant approach is almost only available
in clinical studies.
Acute leukaemia used to be nearly always fatal, but now it has a 63% 5-year survival
rate in the US. The therapeutic options for acute leukaemia have increased with the
introduction of immunotherapy, however, the advancement in AML has been slower.
Novel medicines such as ADCs, CAR T cell treatments, and BiTEs continue to show
remarkable response rates and favourable toxicity profiles in various disease states
every year. Even with these developments, a large number of patients are still not
eligible for immunotherapeutic treatments, and relapses following some of the more
recent modalities are still linked to extremely poor prognoses. In the future, new
medicines with potentially unique mechanisms of action will probably be approved
together with the expansion of the indications for currently available medications.
References:
1. Leukemia. National Cancer Institute. Available at:
https://www.cancer.gov/types/leukemia/hp/adult-aml-treatment-pdq
2. Boyiadzis MM, Aksentijevich I, Arber DA, et al. The Society for Immunotherapy
of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of
acute leukemia. Journal for ImmunoTherapy of Cancer. 2020
3. Kantarjian, H., Kadia, T., DiNardo, C. et al. Acute myeloid leukemia: current
progress and future directions. Blood Cancer J. 2021
4. Subklewe M, Bücklein V, Sallman D, Daver N. Novel immunotherapies in the
treatment of AML: is there hope? Hematology Am Soc Hematol Educ Program. 2023
Dec 8;2023
Share:
More Posts
Hereditary Cancers: Is Cancer in your DNA? Find out and take Charge!
Hereditary Cancers: Is Cancer in your DNA? Find out and take Charge! Imagine if you could predict your risk of developing cancer and take steps to prevent it – sounds like something out of science fiction, right? But thanks to modern genetic science, this is possible! Cancer is often seen as a disease that occurs randomly, but in some cases, it runs in families due to inherited genetic mutations. These are known as hereditary cancers, which means the risk of developing certain type of cancer is passed down from parents to children. What are Hereditary Cancers? Think of your DNA as your body’s instruction manual. Sometimes, small errors (mutations) in certain genes could increase the risk of occurrence of cancer. These mutations can be inherited causing certain types of cancers forming a pattern, putting multiple family members at risk. Approximately 5% to 10% of cancers are attributable to a hereditary cancer predisposition syndrome. The most common hereditary cancers include: Breast, Ovarian and Prostate, Pancreatic cancers and Melanoma Colon Cancer and related cancers including endometrium, gastric, small bowel, glioblastoma, ureter, or renal pelvis. Breast, Uterus and Thyroid cancers Certain types of Leukemia Colon cancers with polyps, non-cancerous polyps in colon, gastric and duodenum. Kidney Cancers and multi-system disorder characterized by abnormal growth of blood vessels (called hemangioblastomas or angiomas). Hemangioblastomas may develop in the retina, certain areas of the brain, the spinal cord. But here’s the catch – just because cancer runs in your family doesn’t mean you will definitely get it! It just means you need to be extra vigilant. Who is at Risk for Hereditary Cancers? Multiple family members (on the same side – could be either paternal or maternal) have had the same type of cancer or related cancers. Did any relative get cancer at a young age (before 50)? Did someone in your family have two or more types of cancer? Has a male relative had breast cancer? A known genetic mutation (eg:BRCA) If you answered YES to any of these, you might have a hereditary cancer risk! But don’t panic—there’s a lot you can do to protect yourself. Genetic Testing: Your Secret Weapon Against Cancer! Imagine if you could predict the weather months in advance and prepare for a storm. That’s what genetic testing does for cancer—it tells you your risk before cancer strikes! I Have a High Risk… What Now? A high genetic risk doesn’t mean cancer is guaranteed. It just means you can get ahead of it with these strategies: Early & Frequent Screening – Catch It Before It Starts! Eat Smart: Load up on fresh fruits, vegetables, and whole grains. Move More: 30 minutes of exercise a day can cut cancer risk significantly! Ditch Smoking & Limit Alcohol: These are major cancer risk factors. Maintain a Healthy Weight: Obesity increases cancer risk—stay in shape! Talking About Cancer: Breaking the Silence in Indian Families In many Indian households, cancer is a taboo topic. Families avoid discussing genetic risks because of marriage prospects, fear, or stigma. But staying silent can be dangerous. In many Indian households, cancer is a taboo topic. Families avoid discussing genetic risks because of marriage prospects, fear, or stigma. But staying silent can be dangerous. By sharing your family’s cancer history, you can protect your loved ones! Know your family history. Consider genetic testing if you’re at risk. Take action with screening, lifestyle changes, or medical options. Start a conversation—help others in your family! Cancer doesn’t have to be a surprise. With the right information, you can stay ahead and live a long, healthy life! Book an Appointment
How Immunotherapy Works for Throat Cancer?
How Immunotherapy Works for Throat Cancer? Throat cancer, a type of head and neck cancer, affects the throat, voice box, or tonsils. Traditional treatments like surgery, chemotherapy, and radiation have long been the standard. However, medical advancements have led to the emergence of immunotherapy, a revolutionary treatment that enhances the body’s immune system to fight cancer effectively. Understanding Immunotherapy for Throat Cancer Immunotherapy is a form of cancer treatment that helps the body’s immune system recognize and attack cancer cells. Unlike chemotherapy, which directly kills cancer cells, immunotherapy works by boosting the body’s natural defenses. It is particularly effective for patients with advanced or recurrent throat cancer who may not respond well to conventional treatments. Types of Immunotherapy Used for Throat Cancer Checkpoint Inhibitors: These drugs block proteins like PD-1/PD-L1 that prevent the immune system from attacking cancer cells. Monoclonal Antibodies: These lab-made proteins attach to cancer cells and help the immune system destroy them. Cancer Vaccines: These stimulate the immune system to target cancer cells more effectively. Adoptive Cell Therapy: This involves modifying a patient’s immune cells to attack cancer cells more efficiently. How Healius Cancer & Hematology Clinics Provide the Best Immunotherapy for Throat Cancer At Healius Cancer & Hematology Clinics, we are committed to offering cutting-edge immunotherapy for throat cancer, ensuring the best possible outcomes for our patients. Our expert oncologists, led by Dr. Mangesh Kamath, specialize in personalized cancer care tailored to each patient’s unique needs. Why Choose Healius for Immunotherapy? Personalized Treatment Plans: Each patient undergoes a thorough evaluation to determine the most effective immunotherapy approach. Advanced Diagnostic Tools: Our clinics use state-of-the-art technology to assess cancer progression and treatment response. Multidisciplinary Team: Our oncologists, hematologists, and support staff work together to provide holistic care. Access to Clinical Trials: Patients at Healius may have the opportunity to participate in advanced immunotherapy clinical trials. Who Can Benefit from Immunotherapy for Throat Cancer? Patients with advanced or metastatic throat cancer Those who have not responded well to chemotherapy or radiation Patients with high PD-L1 expression, making them more responsive to immunotherapy Individuals looking for less toxic alternatives to traditional cancer treatments Conclusion Immunotherapy has transformed the landscape of throat cancer treatment, offering new hope to patients who previously had limited options. At Healius Cancer & Hematology Clinics, we provide world-class immunotherapy treatments, ensuring the highest standard of cancer care. If you or a loved one is battling throat cancer, consult with Dr. Mangesh Kamath and team at Healius Cancer & Hematology Clinics to explore the best treatment options available. Book an Appointment Today! Take the first step toward advanced cancer care. Contact Healius Cancer & Hematology Clinics today to schedule a consultation. Book an Appointment
Advances in Gallbladder & Bile Duct Cancer Treatment
Advances in Gallbladder & Bile Duct Cancer Treatment: What You Should Know Gallbladder and bile duct cancers are rare but aggressive forms of cancer that require early detection and advanced treatment for the best outcomes. At Healius Cancer & Hematology Clinics, we specialize in providing cutting-edge therapies, ensuring that patients receive the best cancer treatment in Bangalore. With a team of experienced oncologists and state-of-the-art technology, our focus is on delivering personalized and effective care at an affordable cancer treatment center. Breakthroughs in Gallbladder & Bile Duct Cancer Treatment 1. Advanced Surgical Techniques for Better Outcomes Surgery remains the most effective treatment for early-stage gallbladder and bile duct cancers. At Healius Cancer & Hematology Clinics, our expert surgeons use minimally invasive techniques such as laparoscopic and robotic-assisted surgery to remove tumors with precision, leading to faster recovery times and fewer complications. 2. Targeted Therapy: A Personalized Approach Unlike traditional chemotherapy, targeted therapy focuses on attacking cancer cells while sparing healthy tissue. This approach has shown promising results in treating advanced gallbladder and bile duct cancers. Our specialists at Healius Cancer & Hematology Clinics, a leading cancer hospital in Bangalore, use advanced molecular profiling to identify the most effective targeted treatments for each patient. 3. Immunotherapy: Boosting the Body’s Defense Against Cancer Immunotherapy is revolutionizing cancer care by enhancing the body’s immune system to fight cancer cells. Newer drugs like checkpoint inhibitors are being used to treat bile duct cancers, improving survival rates and quality of life. Our oncologists are at the forefront of offering these innovative therapies. 4. Precision Radiation Therapy for Higher Effectiveness Radiation therapy has evolved significantly, and modern techniques such as IMRT (Intensity-Modulated Radiation Therapy) and SBRT (Stereotactic Body Radiation Therapy) allow us to target tumors with high precision, minimizing damage to surrounding organs. Healius Cancer & Hematology Clinics ensures access to these advanced radiation treatments at an affordable cancer treatment center. 5. Minimally Invasive and Palliative Care for Advanced Cases For patients with advanced-stage bile duct and gallbladder cancer, minimally invasive procedures such as stent placements can help relieve symptoms and improve quality of life. Our specialists focus on comprehensive palliative care to ensure comfort and support throughout the treatment journey. Why Choose Healius Cancer & Hematology Clinics? Best cancer treatment in Bangalore with advanced medical technology. Experienced team of oncologists providing personalized treatment plans. Affordable cancer treatment with comprehensive care options. Holistic approach, including nutritional guidance, pain management, and emotional support. Take the Next Step in Cancer Care If you or a loved one is facing gallbladder or bile duct cancer, early intervention and expert care can make all the difference. Visit Healius Cancer & Hematology Clinics, a trusted cancer hospital in Bangalore, for world-class treatment at an affordable cost. Book an Appointment
How Lifestyle Changes Can Reduce the Risk of Kidney Cancer
How Lifestyle Changes Can Reduce the Risk of Kidney Cancer Kidney cancer is one of the most commonly diagnosed cancers worldwide, but the good news is that certain lifestyle changes can significantly reduce the risk. At Healius Cancer & Hematology Clinics, our expert team, led by Dr. Mangesh, emphasizes preventive care alongside advanced cancer treatment. As the best cancer hospital in Bangalore, we believe in educating people about healthy habits that can lower their risk of developing kidney cancer. 1. Maintain a Healthy Weight Obesity is a major risk factor for kidney cancer. Excess body fat increases inflammation and alters hormone levels, which can contribute to cancer development. Regular exercise and a balanced diet rich in fruits, vegetables, and lean proteins can help maintain a healthy weight. 2. Stay Hydrated and Avoid Excess Salt Drinking enough water helps flush toxins from the kidneys, reducing the risk of kidney disease and cancer. Avoiding excessive salt intake is also crucial, as high sodium levels can elevate blood pressure, putting extra strain on the kidneys. 3. Quit Smoking Smoking doubles the risk of kidney cancer by exposing the body to harmful chemicals that damage kidney cells. If you’re struggling to quit, seek professional support. Healius Cancer & Hematology Clinics offers guidance on smoking cessation as part of our holistic cancer prevention approach. 4. Control Blood Pressure and Diabetes Hypertension and diabetes increase the strain on kidneys, making them more vulnerable to cancer. Regular check-ups, medication, and lifestyle changes like reduced sugar intake and regular physical activity can help keep these conditions under control. 5. Avoid Overuse of Painkillers Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) can harm kidney function. Always consult a doctor before using painkillers frequently, and explore alternative pain management options. 6. Regular Health Check-ups at an Affordable Cancer Hospital Early detection is key to preventing kidney cancer. At Healius Cancer & Hematology Clinics, we offer advanced screenings and diagnostics at an affordable cancer hospital to ensure that every patient gets the best possible care. Regular check-ups can help detect any abnormalities early, improving the chances of successful treatment. Take Charge of Your Kidney Health Today! Preventing kidney cancer starts with simple lifestyle changes. Whether it’s maintaining a healthy weight, quitting smoking, or staying hydrated, small efforts can make a big difference. If you’re looking for expert guidance, visit Dr. Mangesh & team at Healius Cancer & Hematology Clinics, recognized as the best cancer hospital in Bangalore for comprehensive cancer care. For consultations and screenings, book an appointment today! Book an Appointment
